Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Croft

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Molecular and Biochemical Parasitology|December 1, 1993
Proton NMR lipid profile of Leishmania donovani promastigotesR K Adosraku, M M Anderson, G J Anderson, et al.
Gene Therapy|April 15, 2015
Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccineO Riede, K Seifert, D Oswald, et al.
Journal of Medicinal Chemistry|August 24, 2000
Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazinesM O Khan, S E Austin, C Chan, et al.
Journal of Medicinal Chemistry|February 15, 2001
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicityL Salmon-Chemin, E Buisine, V Yardley, et al.
Journal of Medicinal Chemistry|August 1, 1997
Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridinesS A Gamage, D P Figgitt, S J Wojcik, et al.
Journal of Medicinal Chemistry|February 11, 1998
Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugsC Chan, H Yin, J Garforth, et al.
Journal of Medicinal Chemistry|September 7, 2001
Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agentsC W Wright, J Addae-Kyereme, A G Breen, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2001
Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activityJ Ohkanda, J W Lockman, K Yokoyama, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
In vitro trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitorsR Brun, Y Bühler, U Sandmeier, et al.
Journal of Medicinal Chemistry|November 2, 1999
Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductaseS F Chowdhury, V B Villamor, R H Guerrero, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Molecular and Biochemical Parasitology|December 1, 1993
Proton NMR lipid profile of Leishmania donovani promastigotesR K Adosraku, M M Anderson, G J Anderson, et al.
Gene Therapy|April 15, 2015
Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccineO Riede, K Seifert, D Oswald, et al.
Journal of Medicinal Chemistry|August 24, 2000
Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazinesM O Khan, S E Austin, C Chan, et al.
Journal of Medicinal Chemistry|February 15, 2001
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicityL Salmon-Chemin, E Buisine, V Yardley, et al.
Journal of Medicinal Chemistry|August 1, 1997
Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridinesS A Gamage, D P Figgitt, S J Wojcik, et al.
Journal of Medicinal Chemistry|February 11, 1998
Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugsC Chan, H Yin, J Garforth, et al.
Journal of Medicinal Chemistry|September 7, 2001
Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agentsC W Wright, J Addae-Kyereme, A G Breen, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2001
Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activityJ Ohkanda, J W Lockman, K Yokoyama, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
In vitro trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitorsR Brun, Y Bühler, U Sandmeier, et al.
Journal of Medicinal Chemistry|November 2, 1999
Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductaseS F Chowdhury, V B Villamor, R H Guerrero, et al.
Pageof 12